COST-EFFECTIVENESS AND PUBLIC HEALTH IMPACT OF A NINE-VALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN UKRAINE

被引：0
|
作者：
Ugrekhelidze, D. [1 ]
Pavelyev, A. [2 ]
Daniels, V [3 ]
Grubaia, A. [4 ]
Fedotova, K. [4 ]
机构：
[1] MSD, Zurich, Switzerland
[2] Merck & Co Inc, Rahway, NJ USA
[3] Merck & Co Inc, Rahway, NJ USA
[4] MSD, Kiev, Ukraine
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE596
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [1] Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France
    Majed, Laureen
    Bresse, Xavier
    El Mouaddin, Nadia
    Schmidt, Aurelie
    Daniels, Vincent J.
    Pavelyev, Andrew
    Levy-Bachelot, Laurie
    Elbasha, Elamin
    [J]. VACCINE, 2021, 39 (02) : 438 - 446
  • [2] THE PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF SCHOOL-BASED NINE-VALENT HUMAN PAPILLOMAVIRUS FEMALE VACCINATION COMPARED WITH BI-VALENT AND QUADRIVALENT VACCINATION IN MALAYSIA
    Woo, Y.
    Hsu, T.
    Pavelyev, A.
    LeVan, R.
    Prabhu, V. S.
    [J]. VALUE IN HEALTH, 2018, 21 : S7 - S7
  • [3] COST-EFFECTIVENESS OF GENDER-NEUTRAL NINE-VALENT HPV VACCINATION IN DENMARK
    Olsen, J.
    le Fevre, T.
    Blaakaer, J.
    [J]. VALUE IN HEALTH, 2018, 21 : S229 - S229
  • [4] Nine-Valent Human Papillomavirus Vaccine Recommended for Routine Vaccination
    不详
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 60 (11) : I - II
  • [5] ESTIMATING THE COST-EFFECTIVENESS PROFILE OF A VACCINATION PROGRAMME WITH A NINE-VALENT HPV VACCINE IN ITALY
    Mennini, F. S.
    Bianic, F.
    Baio, G.
    Largeron, N.
    Plazzotta, G.
    Rinaldi, A.
    De Waure, C.
    Bonanni, P.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A457 - A457
  • [6] The cost-effectiveness of bivalent, quadrivalent, and nine-valent HPV vaccination in Asia: a systematic review
    Ke Zhu
    Yuke Tian
    Xiaomei Dong
    Babatunde O. Akinwunmi
    Casper J. P. Zhang
    Jian Huang
    Wai-kit Ming
    [J]. Archives of Gynecology and Obstetrics, 2022, 306 : 173 - 187
  • [7] The cost-effectiveness of bivalent, quadrivalent, and nine-valent HPV vaccination in Asia: a systematic review
    Zhu, Ke
    Tian, Yuke
    Dong, Xiaomei
    Akinwunmi, Babatunde O.
    Zhang, Casper J. P.
    Huang, Jian
    Ming, Wai-kit
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 306 (01) : 173 - 187
  • [8] Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
    Mennini, Francesco Saverio
    Bonanni, Paolo
    Bianic, Florence
    de Waure, Chiara
    Baio, Gianluca
    Plazzotta, Giacomo
    Uhart, Mathieu
    Rinaldi, Alessandro
    Largeron, Nathalie
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2017, 15
  • [9] Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
    Francesco Saverio Mennini
    Paolo Bonanni
    Florence Bianic
    Chiara de Waure
    Gianluca Baio
    Giacomo Plazzotta
    Mathieu Uhart
    Alessandro Rinaldi
    Nathalie Largeron
    [J]. Cost Effectiveness and Resource Allocation, 15
  • [10] ESTIMATING THE COST-EFFECTIVENESS PROFILE OF A UNIVERSAL VACCINATION PROGRAMME WITH A NINE-VALENT HPV VACCINE IN AUSTRIA
    Boiron, L.
    Joura, E.
    Largeron, N.
    Prager, B.
    Nikoglou, T.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A585 - A585
12345